Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers.

Author: Asbrink NilssonE, HedlinG, MöllerC, NordvallS L, WennergrenG, WilleS

Paper Details 
Original Abstract of the Article :
Maintenance treatment with nebulized budesonide was studied in young children with asthma not controlled without steroids. In a blind parallel-group study for 18 weeks, 102 children, mean age 22 (5- 47) months, were randomized for treatment starting with 0.25 or 1 mg b.i.d. The patients were reviewe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1651-2227.1996.tb13989.x

データ提供:米国国立医学図書館(NLM)

Nebulized Budesonide: A Treatment for Moderate to Severe Asthma in Young Children

The field of [pediatric asthma] seeks effective and safe treatments for young children suffering from [moderate to severe asthma]. This study investigates the efficacy of [nebulized budesonide] as a [maintenance treatment] for [asthma] in [infants and toddlers]. The authors conducted a [blind, parallel-group study] to assess the effectiveness of [nebulized budesonide] in managing [asthma symptoms] over an 18-week period.

The study's findings indicate that [nebulized budesonide] is effective in controlling [asthma symptoms] in [infants and toddlers]. The authors observed good clinical effects with both high and low starting doses of [budesonide]. This is akin to a desert oasis offering a refreshing respite, regardless of the starting point of the journey. The study highlights the importance of [duration of therapy] in achieving long-term symptom control.

The authors conclude that [nebulized budesonide] is a safe and effective treatment for [moderate to severe asthma] in [infants and toddlers]. The study emphasizes the importance of individualized dose adjustments and ongoing monitoring to ensure optimal outcomes.

Budesonide: A Safe and Effective Treatment for Young Children with Asthma

The study confirms the effectiveness of [nebulized budesonide] as a [maintenance treatment] for [asthma] in [infants and toddlers]. The authors observed good clinical effects with both high and low starting doses of [budesonide], suggesting that a personalized approach to treatment is crucial.

A Breath of Fresh Air: Managing Asthma in Young Children

This research underscores the importance of having effective treatments for [asthma] in [infants and toddlers]. The study confirms the efficacy of [nebulized budesonide], offering a safe and effective option for managing [asthma symptoms] in this vulnerable population.

Dr. Camel's Conclusion

This research highlights the efficacy and safety of nebulized budesonide as a maintenance treatment for moderate to severe asthma in infants and toddlers. The study offers a valuable tool for managing asthma symptoms in young children, emphasizing the importance of individualized dose adjustments and ongoing monitoring to ensure optimal outcomes.

Date :
  1. Date Completed 1996-07-15
  2. Date Revised 2019-08-21
Further Info :

Pubmed ID

8640047

DOI: Digital Object Identifier

10.1111/j.1651-2227.1996.tb13989.x

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.